Literature DB >> 30217514

The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis.

Jingming Zhao1, Wei Cheng2, Xigang He3, Yanli Liu2.   

Abstract

PURPOSE: The co-colonization prevalence of P. aeruginosa and A. fumigatus in cystic fibrosis (CF) has been inconsistently reported. The purpose of this systematic review and meta-analysis was to estimate the overall co-colonization prevalence of P. aeruginosa and A. fumigatus in CF.
METHODS: The Embase, PubMed and Web of Science databases were systematically searched for studies reporting the co-colonization prevalence of P. aeruginosa and A. fumigatus in CF. The co-colonization prevalence of two pathogenic microorganisms in the individual studies was assessed by calculating the proportion and 95% confidence interval (CI). The random effects model was used to calculate the pooled prevalence. The I2 test was used to assess statistical heterogeneity. The funnel plot and two statistical methods were used to assess publication bias.
RESULTS: Twenty-three eligible studies were included in this analysis. The pooled co-colonization prevalence of P. aeruginosa and A. fumigatus in CF patients was 15.8% (95% CI: 9.9-21.8). The co-colonization prevalence of P. aeruginosa and A. fumigatus chronic colonization was lower than that of intermittent colonization, higher in sputum cultures than in bronchoalveolar lavage (BAL) cultures, and lower in children than in adults. There was a statistically significant difference in co-colonization prevalence among studies from different decades, but the prevalence was similar in different geographical regions and with different study types.
CONCLUSIONS: The co-colonization prevalence of P. aeruginosa and A. fumigatus in the lower respiratory tract of CF patients was high. The anti-infective treatment in exacerbation of CF should be considered to cover the two pathogenic microorganisms simultaneously. Large-scale research is still needed to obtain more accurate co-colonization data.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aspergillus fumigatus; Cystic fibrosis; Meta-analysis; Prevalence; Pseudomonas aeruginosa

Mesh:

Year:  2018        PMID: 30217514     DOI: 10.1016/j.micpath.2018.09.010

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  15 in total

Review 1.  Aspergillus fumigatus and Aspergillosis in 2019.

Authors:  Jean-Paul Latgé; Georgios Chamilos
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

2.  Molecular Modifications of the Pseudomonas Quinolone Signal in the Intermicrobial Competition with Aspergillus.

Authors:  Hasan Nazik; Gabriele Sass; Paul Williams; Eric Déziel; David A Stevens
Journal:  J Fungi (Basel)       Date:  2021-04-28

Review 3.  Bronchial Epithelial Cells on the Front Line to Fight Lung Infection-Causing Aspergillus fumigatus.

Authors:  Jeanne Bigot; Loïc Guillot; Juliette Guitard; Manon Ruffin; Harriet Corvol; Viviane Balloy; Christophe Hennequin
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

4.  The Association of Cerebrovascular Disease with Adverse Outcomes in COVID-19 Patients: A Meta-Analysis Based on Adjusted Effect Estimates.

Authors:  Jie Xu; Wenwei Xiao; Xuan Liang; Peihua Zhang; Li Shi; Ying Wang; Yadong Wang; Haiyan Yang
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-08-28       Impact factor: 2.136

Review 5.  Factoring in the Complexity of the Cystic Fibrosis Lung to Understand Aspergillus fumigatus and Pseudomonas aeruginosa Interactions.

Authors:  Emily Beswick; Jorge Amich; Sara Gago
Journal:  Pathogens       Date:  2020-08-06

6.  Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis.

Authors:  Jingming Zhao; Wencheng Yu
Journal:  PeerJ       Date:  2018-11-09       Impact factor: 2.984

7.  Pseudomonas aeruginosa-Derived Volatile Sulfur Compounds Promote Distal Aspergillus fumigatus Growth and a Synergistic Pathogen-Pathogen Interaction That Increases Pathogenicity in Co-infection.

Authors:  Jennifer Scott; Monica Sueiro-Olivares; Waqar Ahmed; Christoph Heddergott; Can Zhao; Riba Thomas; Michael Bromley; Jean-Paul Latgé; Sven Krappmann; Stephen Fowler; Elaine Bignell; Jorge Amich
Journal:  Front Microbiol       Date:  2019-10-09       Impact factor: 6.064

8.  A Peculiar Case of Pneumonia due to Mycoplasma pneumoniae in a Child with Cystic Fibrosis and Sensibilization to Aspergillus fumigatus.

Authors:  Laura Peccini; Serena Pennoni; Valeria Mencarini; Marco Saponara; Nicola Palladino; Nicola Principi; Guido Pennoni; Susanna Esposito
Journal:  Pathogens       Date:  2019-12-22

Review 9.  Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis.

Authors:  Cecilia Velino; Francesca Carella; Alessio Adamiano; Maurizio Sanguinetti; Alberto Vitali; Daniele Catalucci; Francesca Bugli; Michele Iafisco
Journal:  Front Bioeng Biotechnol       Date:  2019-12-17

10.  Virus Infection of Aspergillus fumigatus Compromises the Fungus in Intermicrobial Competition.

Authors:  Hasan Nazik; Ioly Kotta-Loizou; Gabriele Sass; Robert H A Coutts; David A Stevens
Journal:  Viruses       Date:  2021-04-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.